Drugs / IVOSPEMIN
IVOSPEMIN
also known as
SUN-101 · SBP-101 · IVOSPEMIN HYDROCHLORIDE · Ivospemin tetrahydrochloride · Longhala Magnair · SBP-101 TETRAHYDROCHLORIDE
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Filed | US (FDA) | — | — | — | “ネブライザーで投与する長時間作用性抗コリン薬（LAMA）SUN-101/eFlowⓇ（グリコピロニウム臭 化物）は、今年7月にFDAへ新薬申請をいたしました。” nxera.life ↗ |
Trials 7
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IVOSPEMIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | IVOSPEMIN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | Ivospemin tetrahydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | Longhala Magnair | “Longhala™ Magnair™ (glycopyrrolate) Inhalation Solution, a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system...” PMID 30584583 ↗ Jun 2018 |
| Known as | SBP-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05254171 ↗ |
| Known as | SBP-101 TETRAHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL80386 ↗ |
| Known as | SUN-101 | “SUN-101 3 mcg bid” NCT02038829 ↗ |
| Modality | Other / unclassified | “a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system (eFlow CS) nebulizer” PMID 30584583 ↗ Jun 2018 |
| Route | Inhaled | “via eFlow Closed System (CS) nebulizer” NCT02276222 ↗ |